⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for adult b acute lymphoblastic leukemia

Every month we try and update this database with for adult b acute lymphoblastic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell TransplantationNCT04626726
Adult B Acute L...
CD19 CAR-T
CD22 CAR-T
CD19+CD22 CAR-T
Fludarabine
Cyclophosphamid...
14 Years - 65 YearsHebei Senlang Biotechnology Inc., Ltd.
Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic LeukemiaNCT02997761
Adult B Acute L...
Philadelphia Ch...
Blinatumomab
Ibrutinib
18 Years - University of California, Davis
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic LeukemiaNCT00075725
Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 YearsChildren's Oncology Group
Veliparib and Temozolomide in Treating Patients With Acute LeukemiaNCT01139970
Acute Lymphobla...
Acute Myeloid L...
Acute Myeloid L...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Pro...
Adult B Acute L...
Adult B Acute L...
Adult T Acute L...
Alkylating Agen...
Chronic Myelomo...
Recurrent Adult...
Recurrent Adult...
Secondary Acute...
Laboratory Biom...
Pharmacological...
Temozolomide
Veliparib
18 Years - National Cancer Institute (NCI)
Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)NCT00866307
Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Prophylactic Cr...
Thioguanine
Vincristine Sul...
1 Year - 30 YearsChildren's Oncology Group
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic LeukemiaNCT00075725
Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 YearsChildren's Oncology Group
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic LeukemiaNCT00792948
Acute Lymphobla...
Adult B Acute L...
Adult B Acute L...
Adult L1 Acute ...
Adult L2 Acute ...
Adult T Acute L...
Recurrent Adult...
Allogeneic Hema...
Cyclophosphamid...
Cytarabine
Dasatinib
Dexamethasone
Doxorubicin Hyd...
Etoposide
Filgrastim
Laboratory Biom...
Leucovorin Calc...
Methotrexate
Methylprednisol...
Peripheral Bloo...
Prednisone
Sirolimus
Tacrolimus
Total-Body Irra...
Vincristine Sul...
18 Years - 60 YearsNational Cancer Institute (NCI)
Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic LeukemiaNCT02997761
Adult B Acute L...
Philadelphia Ch...
Blinatumomab
Ibrutinib
18 Years - University of California, Davis
Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell TransplantationNCT04626726
Adult B Acute L...
CD19 CAR-T
CD22 CAR-T
CD19+CD22 CAR-T
Fludarabine
Cyclophosphamid...
14 Years - 65 YearsHebei Senlang Biotechnology Inc., Ltd.
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic LeukemiaNCT00075725
Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 YearsChildren's Oncology Group
Veliparib and Temozolomide in Treating Patients With Acute LeukemiaNCT01139970
Acute Lymphobla...
Acute Myeloid L...
Acute Myeloid L...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Pro...
Adult B Acute L...
Adult B Acute L...
Adult T Acute L...
Alkylating Agen...
Chronic Myelomo...
Recurrent Adult...
Recurrent Adult...
Secondary Acute...
Laboratory Biom...
Pharmacological...
Temozolomide
Veliparib
18 Years - National Cancer Institute (NCI)
Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic LeukemiaNCT02129062
Adult B Acute L...
Adult B Acute L...
Recurrent Adult...
Ibrutinib
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
Veliparib and Temozolomide in Treating Patients With Acute LeukemiaNCT01139970
Acute Lymphobla...
Acute Myeloid L...
Acute Myeloid L...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Pro...
Adult B Acute L...
Adult B Acute L...
Adult T Acute L...
Alkylating Agen...
Chronic Myelomo...
Recurrent Adult...
Recurrent Adult...
Secondary Acute...
Laboratory Biom...
Pharmacological...
Temozolomide
Veliparib
18 Years - National Cancer Institute (NCI)
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV InfectionNCT02109224
Adult B Acute L...
Chronic Lymphoc...
Cutaneous B-Cel...
Extranodal Marg...
HIV Infection
Intraocular Lym...
Multicentric An...
Nodal Marginal ...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Grade...
Recurrent Grade...
Recurrent Grade...
Recurrent Mantl...
Recurrent Margi...
Recurrent Small...
Refractory Chro...
Refractory Hair...
Refractory Plas...
Small Intestina...
Splenic Margina...
Testicular Lymp...
Waldenstrom Mac...
Ibrutinib
Laboratory Biom...
Pharmacological...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: